June 20, 2024 09:58 AM EDT
News Briefing

For­bion's new €75M fund; Cara Ther­a­peu­tics to cut work­force af­ter tri­al fail­ure

ENDPOINTS

Plus, news about Cin­clus Phar­ma, Bio­phytis and Blan­ver:

For­bion’s new fund: The Dutch VC firm’s BioE­con­o­my Fund I closed €75 mil­lion …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

The End­points 11 win­ners: Big bets on AI, new fron­tiers in edit­ing, a neu­ro re­nais­sance and Chi­nese chem­istry

No­vo Nordisk to de­crease some in­sulin pen man­u­fac­tur­ing, tran­si­tion sup­ply

Ex­clu­sive: J&J folds car­dio­vas­cu­lar and meta­bol­ic drug unit

Cas­sa­va and its for­mer ex­ecs set­tle SEC charges for ‘mis­lead­ing’ Alzheimer’s drug da­ta

FDA ap­proves Dupix­ent in COPD, open­ing ‘next chap­ter’ for Sanofi and Re­gen­eron’s best­seller

sponsored

PD­Cs vs. AD­Cs: A New Fron­tier in Tar­get­ed Can­cer Ther­a­pies and the Po­ten­tial for De­vel­op­ment Part­ner­ships

A service from the Financial Times